Introduction
============

The beef industry is a major component of the U.S. agricultural economy and is worth an estimated \$175 billion. Approximately 800,000 ranchers and cattlemen conduct business in all 50 states and contribute economically to nearly every county in the nation (<http://www.beefusa.org>). For many years, beef was the number one source of protein in American diets. However, the eating habits of American consumers have changed considerably over the last three to four decades [@B1]. Per capita consumption of beef has fallen from an all-time high of 42.77 Kg in 1976 (American Meat Institute, 2009) to 27.08 Kg in 2010 [@B2]. As a result, in order to increase consumption and profitability, commercial cow-calf producers must address and find ways to optimize a number of economically important beef quality traits, such as insufficient marbling, low quality grades, inadequate meat tenderness, low curability, inadequate muscling, and excess fat cover [@B3]. Implementation of technologies and systems that tackle these challenges is essential to reduce costs and enhance productivity of beef production. One of the oldest and most fundamental principles to enable these outcomes is crossbreeding.

Indeed, crossbreeding beef cattle has routinely been a powerful method to improve and/or optimize a number of economically important traits, such as reproduction, growth, maternal ability, and end product quality; which has resulted in reduced costs of production in order to remain competitive in the industry. For example, based on the least square mean estimates from crossbreeding studies published in the literature from 1976 to 1996, Williams and colleagues [@B4] reported that direct breed effects range from -0.5 ± 0.14 kg (British Dairy) to 10.1 ± 0.46 kg (Continental Beef) for birth weight, from -7.0 ± 0.67 kg (British Dairy) to 29.3 ± 0.74 kg (Simmental) for weaning weight, from -17.9 ± 1.64 kg (Brahman) to 21.6 ± 1.95 kg (Charolais) for postweaning body weight gain, from -6.5 ± 1.29 kg (Brahman) to 55.8 ± 1.47 kg (Continental Beef) for carcass weight, from -8.1 ± 0.48 cm^2^ (Shorthorn) to 21.0 ± 0.48 cm^2^ (Continental Beef) for ribeye area and from -1.1 ± 0.02 cm (Continental Beef) to 0 ± 0.00 cm (Angus) for fat thickness, respectively. These results indicate that crossbreeding takes advantage of heterosis and breed complementarities to maximize the productivity and profitability of beef enterprises as compared to purebreeding.

Wagyu beef cattle include the Japanese Black, Japanese Brown, Japanese Poll, and Japanese Shorthorn [@B5]. In general, Wagyu cattle produce highly marbled beef with high amounts of monounsaturated fatty acids (MUFA) plus a large ribeye area compared with other beef breeds. For example, carcasses of Wagyu sired calves had greater marbling scores (Slightly abundant 771 vs. Modest 594, P = 0.0001), greater intramuscular fat content (12.0% vs. 10.5%, P \< 0.02) and greater ribeye area (80.5 cm^2^ vs. 76.6 cm^2^, P = 0.08) at the 12th rib than those of Angus [@B6]. Investigation of fatty acid compositions among 34 sire groups of Wagyu revealed that the mean percentages of MUFA in intramuscular fat ranged from 47.71 to 54.77% [@B7], while MUFA was only 38.53% in Aberdeen Angus [@B8].

In our previous study, we reported genetic networks associated with 19 complex phenotypes in a Wagyu x Limousin F~2~reference population using a total of 138 genetic polymorphisms derived from 71 known functional genes [@B9]. These genes are involved in various pathways, such as nuclear encoded mitochondrial genes, the long chain fatty acids uptake gene complex, the sauvagine/corticotropin-releasing factor/urotensin Ι family and related families, the lipogenesis/lipolysis enzymes, calpain/calpasatin or related genes and others. Subsequently, we discovered that the genes from the reverse cholesterol transport pathway as well as the heparin and heparin metabolism pathway are also useful targets for improving meat quality and fatty acid composition in beef cattle [@B10]-[@B11]. In the present study, we tested these previously reported SNPs plus many newly developed SNPs in a Wagyu x Angus F~1~reference population measured for six carcass traits and twenty-four fatty acid composition phenotypes and revealed single-gene associations for 10 traits, but revealed two-gene networks for 9 traits and three-gene networks for 8 traits. These results clearly showed that these important families or pathway-based genes are useful targets for improving meat quality traits and healthful beef products in cattle.

MATERIAL AND METHODS
====================

Cattle and phenotypic information
---------------------------------

A Wagyu×Angus F~1~ population was used in the present study, including 43 Wagyu bulls as sires and their 791 potential progeny. Among them, 396 F~1~ animals were sampled in 2006 and 395 in 2007. This population was jointly developed by Washington State University and Merial Ltd. We focused on a total of 30 phenotypic measurements, which can be classified into two categories: 1) six carcass measurements: hot carcass weight (HCW), ribeye area (REA), backfat (BFT), beef marbling score (BMS), quality grade (QG), and adjusted yield grade (YG), and 2) twenty-four fatty acid composition phenotypes including A) six saturated fatty acids: myristic acid (C14:0), pentadecanoic acid (C15:0), palmitic acid (C16:0), heptadecanoic acid (C17:0), stearic acid (C18:0), and their sum as saturated fatty acids (SFA); B) seven monounsaturated fatty acids: myristoleic (C14:1n5), pentadecanoic (C15:1n5), palmitoleic acid (C16:1n7), heptadecanoic acid (C17:1n7), vaccenic acid (C18:1n7), oleic acid (C18:1n9), and their sum as monounsaturated acids (MUFA); C) four polyunsaturated fatty acids: conjugated linoleic acid (CLA, C18:2c9,t11)), linoleic acid (OMEGA-6), linolenic acid (OMEGA-3) and their sum as polyunsaturated fatty acids (PUFA); D) two trans-fatty acids: trans-vaccenic acid (C18:1n7t) and linolelaidic (C18:2n6t); and E) five traits related to enzyme activities or others: DELTA 9 desaturase (introduces a double bond at the C9 position of a saturated fatty acid), ELONGASE (lengthens a fatty chain by two carbons due to an acetate addition), OMEGA 6:3 RATIO (the ratio of omega 6 fatty acid content to that of omega 3 fatty acid content; the lower this ratio, the better for human nutrition), TRANS (the trans fatty acid content; generally trans fatty acids are detrimental to human health, but notable exceptions are trans vaccenic acid and CLA), and FAT (the Total amount of fat in a beef sample). Methods and procedures to measure these phenotypes were described previously [@B9], [@B12].

DNA isolation, SNP panel information and genotyping
---------------------------------------------------

DNA from the 43 sires was isolated from blood with the GenElute Blood Genomic DNA kit (Sigma-Aldrich, St. Louis, MO) according to manufacturer\'s instructions. Muscle and fat tissues were collected from the 791 yearling progeny and DNA was isolated with the GenElute Mammalian Genomic DNA Miniprep kit (Sigma-Aldrich, St. Louis, MO) as directed. A total of 182 mutations, mainly single nucleotide polymorphisms (SNPs) derived from 91 functional genes were included in the present study ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Table S1). Genotyping was performed using a Sequenom iPLEX assay service provided by the Genomics Center at the University of Minnesota.

Parentage assignment
--------------------

Based on the genotyping data, we calculated both genotype and allele frequencies in sires and the F~1~ progeny, but only estimated the allele frequencies in dams as F~D(A)~=2F~P(A)~- F~S(A)~(where F~D(A)~, F~P(A)~, and F~S(A)~ represent the frequencies for the same allele in dams, progeny, and sires, respectively) ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Table S2). SNPs/mutations that were in Hardy-Weinberg equilibrium and had a minor allele frequency of \>0.15 were then selected to form a marker panel for parentage assignments. Paternity was assigned after genotyping data from the offspring were analyzed with the Cervus computer program [@B13]-[@B15]. The Cervus software package uses a likelihood-based approach to compute a probability for a true sire even if genotypes of the dams were unknown. The accurate parentage assignment made it possible to pursue the marker-trait association study using a sire model as described below.

Statistical analyses and genetic evaluation
-------------------------------------------

The HAPLOVIEW program [@B16] was used to determine the linkage disequilibrium (LD) relationships among 102 markers located on 23 bovine chromosomes ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Table S2), which lead to selection of tag mutations for further analysis. Comparisons of gene allele and genotype frequencies in each tag SNP were carried out using the *chi-squared* test of SAS Software for Windows v9.2 (SAS Institute Inc., Gary, NC). The phenotypes REA, BFT, BMS and all fatty acid traits were first tested to ensure that the data were normal random distributions. Association analyses were performed using the PROC MIXED procedure of SAS using the following models:

where *y~ijklm~* or *y~ijklmn~* is the phenotypic measurement of a quantitative trait for each animal, *group~i~* is the effect of the i-th cattle population (i=1,2), *sex~j~* is the effect of the j-th sex category (j=1,2), *killdate~k~* is a random effect of the k-th harvest date (j=1,2,...12), *sires~l~* is a random effect of the l-th sire producing each animal (l=1,2,...,40), *HCW* is a covariate, *β* is the coefficient vector corresponding to the covariate *HCW*, *genotype~m~* represents the effects of each genotype at the related SNP locus, and *ε~ijklmn~* is the residual term pertaining to each animal. *P* value \<0.05 was considered statistically significant after Bonferroni correction. Model (1) using *HCW* as a covariate was initially tested on each trait, but it was removed in Model (2) when it did not reach statistical significance (P\>0.05). In fact, *HCW* was included as a covariate in the model for association analysis for only REA, BFT and YG. The effect of SNPs genotype on the phenotypic traits QG and adjusted YG was evaluated using the GLIMMIX procedure of SAS. The GLIMMIX procedure can evaluate the unknown distributions using the Quasi-likelihood analysis [@B17]-[@B18]. Because it was hard to identify the exact distribution of the response to variables QG and YG, the GLIMMIX procedure was performed to clarify the analysis using the same statistical model as above.

Finally, we also employed the quantitative trait modes (QTMs) with additive, dominant, and overdominant effects to identify novel genetic networks or gene-gene combined effects related to these 30 traits. Only significant markers that had ≥15 animals in each genotype group were examined for the QTMs followed by linear regression model analysis for selection of genetic networks. This procedure was described previously [@B9] with minor modifications. Briefly, we classified the single-trait significant associations into three QTMs (additive, dominant, and overdominant mode) based on the pairwise significance tests, and then we integrated these markers along with their QTMs into a linear regression analysis for a given phenotype using the SAS stepwise regression procedure. Akaike\'s information criterion (AIC) [@B19] was used to compare different models, each representing a specific genetic network.

RESULTS
=======

Gene and SNP basics
-------------------

Originally, this set of 182 polymorphic markers was developed on 6 Wagyu x Limousin F~1~ bulls, genotyped on a Wagyu x Limousin F~2~ population, and used to determine their associations with 19 quantitative traits [@B9]. [Supplementary Material](#SM1){ref-type="supplementary-material"}: Table S1 lists all of these polymorphic markers with their gene symbol, description, chromosome number, genome location, mutation types and pathway/functional category. In brief, these markers were derived from 91 functional known genes, which can be classified into seven gene clusters, plus others. Among them, one gene was selected from BTAs (Bos taurus chromosomes) 5, 8, 13, 20 and 21; two genes from BTAs 4, 9, 17, 24, 26 and 28; three genes from BTAs 3 and 15; four genes from BTAs 6, 7, 10 and 19; five genes from BTAs 2, 11, 14 and 16; seven genes from BTAs 23; eight genes from BTA 1 and 18; and nine genes from BTA 29. Fourteen of these markers were monomorphic in the current population. Among the remaining 168 polymorphic markers, 136 passed the Hardy-Weinberg equilibrium (HWE) test (P\>0.05) while 32 failed the test (P\<0.05).

Genotype and allele frequencies for these 168 polymorphic markers are listed in [Supplementary Material](#SM1){ref-type="supplementary-material"}: Table S2. Among 136 markers that passed the HWE test, 38 (27.94%) markers had a fixed allele in one of the parent populations (allele frequency ≥ 0.9). In contrast, among the 32 markers that failed the HWE test, 25 (78.13%) had a fixed allele in either parent (allele frequency ≥ 0.9), including 7 alleles that were fixed in sires and 18 in dams. Ninety of the 136 (66.18%) markers in HWE shared the same minor allele, while the opposite allele was the minor allele in the sire and dam populations in 46 of 136 (33.82%) markers ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Table S2). Among 32 markers in the parent populations that were not in HWE, the minor allele in 19 (59.38%) markers was the same allele, while the minor allele was the opposite allele in 13 (40.63%) markers ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Table S2). In addition, 34 of 136 markers were excluded from additional analysis as their minor allele frequencies were 0.15 or less. Therefore, only 102 markers representing 54 known genes were involved in parentage assignment and linkage disequilibrium analysis ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Table S2).

Parentage assignment in the population
--------------------------------------

In the present study, the dam\'s genotypes were not available so the population genetic parameters were computed only from the sires and calves. All the SNP loci had a mean polymorphic information content of 0.3432, and a mean expected heterozygosity of 0.4427. Based on the genotype frequencies for this SNP panel, the mean probability of identity (PI) is the probability that the genotypes at a single locus do not differ between two randomly-chosen individuals [@B20]. The non-exclusion PI for a combination of 102 SNP markers was 4.06×10^-40^ for our cattle population, suggesting that the chances of a coincidental genotype match between two randomly-chosen animals were extremely low in the Wagyu x Angus F~1~ population.

The SNP marker panel was further employed to estimate the power in parentage assignment. For this purpose, both NE-2P and NE-1P were defined as the probability that a random candidate sire would not be excluded from paternity when the dam\'s genotype was available or not, respectively. Across all loci, we obtained the combined exclusion probability based on NE-1P and NE-2P at every single locus [@B21]. The combined exclusion probability for the set of loci used in the parentage analysis was high: 0.9999 for the first parent and almost 1 for the second parent, which showed an acceptable high exclusion power for the SNPs marker set to identify genetic paternity in the present study. As a result, 40 of 43 herd sires produced over 765 (96.71%) of the calves in our cattle population (Figure [1](#F1){ref-type="fig"}), which demonstrated this marker set was highly efficient in paternity assignment.

Single marker - single trait associations and their QTMs
--------------------------------------------------------

The HAPLOVIEW analysis revealed strong linkage disequilibrium relationships between/among markers in *RCAN1* (r^2^=96-100%), *ALDH4A1* (r^2^=96%), *SCP2* (r^2^=99%), *GPR37* (r^2^=85%), *CAST* (r^2^=97%-100%), *ABCA1* (r^2^=100%), *SLC27A2* (r^2^=100%), *APOB* (r^2^=97%), *CAPN14* (r^2^=100%), *SLC27A4* (r^2^=92-99%), *CRH* (r^2^=100%), *FABP4* (r^2^=100%), *TFB2M* (r^2^=97%), *APOE* (r^2^=90-100%), *CHD9* (r^2^=99%), *FTO* (r^2^=99%), *LIPE* (r^2^=84-98%), *TNF* (r^2^=83%) and *CAPN1* (r^2^=96%) (Figure [2](#F2){ref-type="fig"}). Therefore, 75 SNPs of 102 markers (73.53%) in 54 genes were selected as tagged SNPs for the association study with Bonferroni correction ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Table S2). Carcass traits were recorded on samples collected in both years, while fatty acid profiling was performed only on samples collected in 2007. So after removing samples lacking information on sex and sires as assigned above, 651 animals were used for marker - carcass (6 traits) association analysis and 333 for marker - fatty acid composition (24 phenotypes) association analysis. A total of 142 significant associations were initially discovered (Table [1](#T1){ref-type="table"}). Five of them were removed due to ≤ 15 animals in each genotype group and 24 were excluded after the Bonferroni correction. As such, only 113 single marker associations remained with 29 phenotypes, including 2 with BMS, 4 with REA, 1 with BFT, 7 with QG, 7 with YG, 5 with HCW, 7 with C14:0, 5 with C14:1n5, 1 with C15:0, 2 with C15:1n5, 3 with C16:0, 5 with C16:1n7, 3 with C17:0, 3 with C17:1n7, 4 with C18:1n7t, 5 with C18:1n7, 7 with C18:1n9, 1 with C18:2n6t, 5 with MUFA, 4 with PUFA, 4 with SFA, 5 with CLA, 3 with TRANS, 2 with OMEGA-3, 4 with OMEGA-6, 3 with OMEGA 6:3 RATIO, 3 with DELTA9 desaturase, 4 with ELONGASE, and 4 with Total FAT. No markers were discovered to significantly affect C18:0. These 113 single markers - single trait associations can be further classified into three groups according to three quantitative trait modes (QTMs): 9 with additive, 73 with dominant and 31 with overdominant effects (Table [1](#T1){ref-type="table"}). One marker can be associated with different phenotypes, but with different QTMs. For example, *TNF*\#3 A/T had an additive effect on BMS but an overdominant effect on YG.

Multiple markers-single trait regressions for different genetic networks
------------------------------------------------------------------------

All significant single-marker associations related to each trait along with their QTMs were then involved in a linear regression model analysis to determine genetic networks. Single-trait associations with QG and adjusted YG were excluded because of the non-normal distributions in these two measurements. Based on the lowest AIC values and correlation coefficients (r) \>0.8 between predicted and real genotype values, the regression analysis revealed the best single-gene associations for BMS, REA, BFT, C15:0, C18:2n6t, PUFA, OMEGA-3, OMEGA-6, DELTA9 desaturase, and Total Fat (Figure [3](#F3){ref-type="fig"}); the best two-gene networks for C14:1n5, C15:1n5, C16:0, C17:0, C17:1n7, C18:1n7t, TRANS, OMEGA 6:3 RATIO, and ELONGASE (Figure [4](#F4){ref-type="fig"}); and the best three-gene networks for HCW, C14:0, C16:1n7, C18:1n9, C18:1n7, SFA, MUFA, and CLA (Figure [5](#F5){ref-type="fig"}), respectively. In fact, all of these 52 associations/networks were orchestrated by a total of 19 genes, including *RCAN1*, *ASB3*, *TNF*, *TFB2M*, *CAPN12*, *FADS2*, *CAST*, *UTS2R*, *APOB*, *CAPN1*, *ABCA1*, *EFEMP1*, *PLTP*, *DSEL*, *SLC27A1*, *SLC27A2*, *LIPE*, *CRH*, and *GNG3* (Figure [6](#F6){ref-type="fig"}). Among them, 12 genes had pleiotropic effects because each influenced multiple phenotypic traits.

DISCUSSION
==========

Candidate gene approaches have been widely used to discover and localize causative genes for quantitative traits or complex phenotypes. There are three ways to choose candidate genes to map quantitative trait loci (QTL) [@B9]. The physiological approach is based on the genes with known biological functions and actions involved in the development or physiology of the trait of interest. The positional cloning approach considers genes that are located in the neighborhood of previously identified QTL regions. The third method is the comparative approach, which takes loci where polymorphisms are known to have a phenotypic effect in one species and explores them as candidates for similar variation in other species. In fact, we used all of these approaches to select candidate genes ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Table S1) for identification of genetic markers responsible for variation in quantitative traits using a Wagyu×Angus F~1~ reference population (the present study) and a Wagyu x Limousin F~2~ reference population [@B9] -[@B11]. The Wagyu×Angus F~1~ reference population included 43 Wagyu bulls, an unknown number of Angus dams and their potential 791 F~1~ progeny, while the Wagyu x Limousin F~2~ reference population consisted of 6 F~1~bulls, 113 F~1~dams and 246 F~2~progeny. With the regression analysis, our present study determined the best single-gene associations for 10 traits (Figure [3](#F3){ref-type="fig"}); the best two-gene networks for 9 traits (Figure [4](#F4){ref-type="fig"}); and the best three-gene networks for 8 traits (Figure [5](#F5){ref-type="fig"}), respectively. These associations/networks were orchestrated by a total of 19 genes, including *ABCA1*, *APOB*, *ASB3*, *CAPN1*, *CAPN12*, *CAST*, *CRH*, *DSEL*, *EFEMP1*, *FADS2*, *GNG3*, *LIPE*, *PLTP*, *RCAN1*, *SLC27A1*, *SLC27A2*, *TFB2M*, *TNF* and *UTS2R*. In the Wagyu x Limousin F~2~ reference population, regression analysis revealed 24 genes that control significant associations/networks for 19 economically important traits, including *APOA1*, *APOE*, *BAK1*, *CAPN1*, *CAPN12*, *CAPN14*, *CRHR1*, *CRHR2*, *CRP*, *FABP3*, *HS6ST1, MTFR1*, *PON1*, *PNPLA2*, *RAB2A*, *RCAN1*, *SCD1*, *SLC2A2*, *SLC27A2*, *TFAM*, *TFB1M*, *UCN3*, *UTS2R* and *UQCRC1*[@B9] - [@B11].

There are only five genes in common between both reference populations and they are *CAPN1*, *CAPN12*, *RCAN1*, *SLC27A2* and *UTS2R.*This result was not unexpected. First, although Wagyu cattle were used as a sire breed to develop both reference populations, dam breeds were quite different between them: Angus for the F~1~ population and Limousin for the F~2~ population. Angus cattle were developed from cattle native to the counties of Aberdeenshire and Angus in Scotland, while Limousin cattle are a breed of highly muscled beef cattle originating from the Limousin and Marche regions of France (<http://www.ansi.okstate.edu/breeds/cattle/>). Second, F~1~ progeny are usually less variable from one another compared to the F~2~ offspring. Third, the number of traits was quite different between both reference populations. In the Wagyu×Angus F~1~ reference population, we measured six carcass phenotypes and twenty-four fatty acid composition traits including six saturated fatty acids, seven monounsaturated fatty acids, four polyunsaturated fatty acids, two trans-fatty acids and five traits related to enzyme activities/others. In the Wagyu x Limousin F~2~ reference population, we focused on a total of 19 phenotypic measurements, which can be classified into three categories: five carcass measurements, six eating quality traits and eight fatty acid composition measurements [@B9]. Lastly, trait ontology is also different. For example, beef marbling score was measured based on the Japanese standard in the F~1~ population (present study), while based on the US standard in the F~2~ population [@B9].

Crossbreeding of two divergent breeds is assumed to produce a relatively large amount of heterozygous animals due to the fixation of opposite alleles in both breeds. However, F~1~ progeny produced in the present study using Wagyu sires and Angus dams did not show such a trend. Among 168 polymorphic markers that were successfully scored, none of them produced all heterozygotes in the F~1~ population. Only 63 SNPs (37.5%, 63/168) had a likely fixed allele in one of the parent populations (allele frequency ≥ 0.9), including 38 that passed and 25 that failed the Hardy-Weinberg equilibrium test ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Table S2). In fact, 109 of the 168 (64.88%) markers shared the same minor allele, while the opposite alleles were the minor alleles between the sire and dam populations only in 59 of 168 (35.12%) markers ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Table S2). Although 44 of 75 (58.67%) tagged markers showed significant differences in both genotype frequencies and allele frequencies between the sire and F~1~ offspring populations, the HET estimates showed no differences in most of markers (52 of 75, 69.33%) between them ([Supplementary Material](#SM1){ref-type="supplementary-material"}: Table S2). In a Wagyu x Limousin F~2~ reference population, Jiang and colleagues (2009) [@B9] observed 1/3 each of additive, dominant and overdominant QTMs for single marker - single trait associations. However, among 113 single markers - single trait associations identified in the present study, only 9 (7.96%, 9/113) were observed with additive, while 73 (64.60%, 73/113) and 31 (27.43%, 31/113) showed the dominant and overdominant effects, respectively (Table [1](#T1){ref-type="table"}) in the Wagyu x Angus F~1~ population. In a specific locus, these results provide initial evidence that heterosis produced by crossbreeding of different breeds might result from the changes of gene action modes rather than from the increased number of heterozygous animals.

Carcass traits are important to determine production efficiency and beef yield. In the present study, we found that *TNF*, a nuclear-encoded mitochondrial gene, significantly affected BMS. TNF is a cytokine that plays critical roles in the regulation of a wide spectrum of biological processes including cell proliferation, differentiation, apoptosis, lipid metabolism, and coagulation [@B22]. Polymorphisms in *TNF* are associated with obesity, immune-inflammatory, and cardiovascular diseases [@B23]-[@B24]. In mice, TNF increased triacylglycerol and diacylglycerol accumulation in skeletal muscle by suppressing AMPK activity via transcriptional up-regulation of protein phosphatase 2C and fatty-acid oxidation [@B25]. Our results further confirmed the roles of TNF in intramuscular fat metabolism.

Obtaining higher values in REA and lower values in BFT represent two major breeding objectives in the beef industry. Our study indicated that *RCAN1* and *ASB3* can significantly impact REA and BFT, respectively. *RCAN1* is a key regulator of calcineurin-nuclear factor of activated T-cells signaling pathway, which has essential roles in growth and differentiation in skeletal muscle [@B26]-[@B27]. In the present study, *RCAN1* showed a dominant effect on REA, which is the most important trait of muscle growth in beef cattle. The finding consists well with its role in muscle growth. *ASB3* is a member of the ankyrin repeat and SOCS box-containing (ASB) family, and it can mediate ubiquitination and degradation of tumor necrosis factor receptor II [@B28]. Until now, little is known about *ASB3*. In the present study, we found this gene has an overdominant effect on BFT.

Three genes, including *TFB2M*, *CAPN12*, and *TNF*, have significant effects on HCW. *TFB2M* is a methyltransferase, which specifically dimethylates the conserved stem loop of mitochondrial 12S rRNA. As such, it plays a primary role in melting the promoter and stabilizing the open promoter complex by simultaneous binding of the priming substrate and the templating DNA base [@B29]. *CAPN12* is a member of the calpain (CAPN) large subunit gene family [@B30]. In the present study, *TFB2M*, *CAPN12*, and *TNF* genes showed dominant effects on HCW. Two genes, *TNF* and *FTO*, also affected both YG and QG in the single-marker association analysis, implying that these genes play important roles in fat deposition, although we could not establish the genetic networks for these two traits.

To date, many research groups have linked genetic markers in *CAPN1*, *CAPN3*, and calpastatin (*CAST*) to beef tenderness [@B31]-[@B33]. Interestingly, we discovered here that both of *CAPN1* and *CAST* genes are involved in gene networks for myristic acid (C14:0), which is positively correlated with tenderness, suggesting that *CAPN1* and *CAST* genes may affect the tenderness by regulating myristic acid. In general, both *CAPN1* and *CAST* belong to the calpain-calpastatin enzyme complexes, which affected the eating quality of meat by regulating the rate of protein degradation [@B34]. As two well-known genes that are associated with beef tenderness, markers from these two genes have been available as genetic markers for commercial application [@B35]. But there is a little known about the relationship of these two genes and fatty acid composition phenotypes. This is not surprising because tenderness is usually measured by Warner-Bratzler shear force and temperature, not by fatty acid composition traits. Our results might provide a novel method for genetic improvement of tenderness in beef cattle.

It is well-known that a diet high in saturated fats tends to increase blood cholesterol levels while diets high in unsaturated fats tend to lower blood cholesterol levels, which in turn have favorable effects on cardiovascular diseases. Unfortunately, since biohydrogenation occurs in the rumen, beef contains more saturated fatty acids than meat of monogastric animals [@B36]. About 80% of the fatty acids in beef are composed of only three fatty acids: two are saturated (palmitic (C16:0) and stearic (C18:0)) and one is unsaturated (oleic acid (C18:1)), while the remaining 20% of fatty acids are distributed among 30 different fatty acids [@B37]. Palmitic acid (C16:0) and stearic (C18:0) account for about 27% and 18% of the fatty acids in beef, respectively. Two genes, *TNF* and *ABCA1*, were involved in the network for palmitic acid (C16:0), while no gene was associated with stearic (C18:0). *ABCA1* plays a key role in reverse cholesterol transport and stimulates cholesterol and phospholipid efflux to apo A-І, which is one of the first stages in reverse cholesterol transport [@B38]. Several SNPs in *ABCA1* are associated with high-density lipoprotein cholesterol (HDL-C) levels in human [@B39]-[@B40], which is a major risk factor for coronary artery disease or obesity. *TNF* also has important roles in obesity or obesity-linked insulin resistance [@B41]. Bradley et al (2008) [@B42] discovered murine adipocytes treated for both 24h and 48h with palmitic acid exhibited a 50-70% increase TNF production, suggested palmitic acid acts directly on adipocytes to modulate cytokine production. Subsequently, it was further confirmed that palmitate induces *TNF* expression in skeletal muscle cells and mouse monocyte lineage [@B43]-[@B44]. Our results also verified these genes are highly associated with major saturated fatty acids.

Oleic acid (C18:1n9), primarily responsible for soft fat, is a major monounsaturated fatty acid, which accounts for about 33% of the fatty acid in beef, and is considered to have the least negative effect on serum cholesterol concentration [@B45]. Our results showed *ABCA1*, *EFEMP1*, and *SLC27A1* genes are involved in the genetic network for oleic acid composition. In fact, unsaturated fatty acids, including oleic acid, can regulate the expression of key genes involved in HDL metabolism [@B46]. Specifically, oleic acid can phosphorylate and destabilize *ABCA1,*a major gene in HDL metabolism*,* through a pholipase D2 pathway and a protein kinase C delta pathway [@B47]-[@B48]. Recently, oleic acid was also found to repress expression of ABCA1 in RAW macrophages by modulating histone acetylation state and LXR-independent posttranslational inhibition [@B49]. Our results confirm the significant relationship of both *ABCA1* and oleic acid. Interestingly, since *ABCA1* was involved in both saturated (palmitic acid) and unsaturated fatty acid traits (oleic acid), we note the same genotype/QTM in the same marker might have different effects on these two types of fatty acid traits, i.e., for ABCA1\#7 marker, AA genotype animals had higher palmitic acid and lower oleic acid levels than that of AG+GG animals. EFEMP1 is a member of the fibulin family of extracellular glycoproteins which are characterized by a fibulin-type C-terminal domain preceded by tandem calcium-binding epidermal growth factor (EGF)-like modules [@B50]-[@B51]. SNPs of *EFEMP1* affect birth length and growth rate in children [@B52]-[@B53]. Little is presently known about the relation of *EFEMP1* and fatty acid composition; however, our results show *EFEMP1* significantly affected oleic acid concentration in beef. SLC27A1 is a plasma membrane protein expressed in adipose tissue, heart, and skeletal muscle [@B54]. Previous studies have demonstrated that depletion of SLC27A1 led to a redistribution of postprandial fatty acid uptake and triglyceride deposition in adipose tissue and muscle of mice [@B55]-[@B56]. In a Wagyu×Limousin reference population, we reported *ABCA1* gene had an additive effect on subcutaneous fat depth (SFD) and an overdominant effect on SFA [@B10]. The present study indicated a dominant effect of *ABCA1* and an overdominant effect of *SLC27A1* in oleic acid (C18:1n9). The above results strongly suggest *ABCA1* and *SLC27A1* are involved in fatty acid and adipose tissue metabolism.

The major polyunsaturated fatty acids found in beef are linoleic acid (C18:2n6/OMEGA-6) (about 3.5%) and alpha-linolenic acid (C18:3n3/OMEGA-3) (about 1.5%). They are both essential fatty acids which cannot be produced in the human body and must be obtained from the diet. Ideally, intake of OMEGA-6 fatty acids should be no more than 10 times that of OMEGA-3 fatty acids [@B57]. But in fact, the ratio of OMEGA-6 to OMEGA-3 in Western diets is 15/1-16.7/1 or more [@B58]. In human, the levels of OMEGA-3 or OMEGA-6 polyunsaturated fatty acid in serum were significantly associated with genetic variants of *NOS3* and *FADS1* respectively [@B59]-[@B60], but our current study did not discover any significant association between *FADS* and OMEGA-6 in beef. Instead, we found *SLC27A2* with an additive effect on OMEGA-6 and *TFB2M* with an overdominant effect on the OMEGA 6:3 RATIO, while *CRH* with an overdominant effect on OMEGA-3 and a dominant effect on the OMEGA 6:3 RATIO in beef. *SLC27A2* plays a key role in lipid biosynthesis and fatty acid degradation. In the previous study, *SLC27A2* was associated with SFD and KPH in beef cattle [@B9], and Wang *et al* (2007) [@B61] reported that a polymorphism in porcine *SLC27A2* gene was associated with fat meat percentage and backfat traits. Our results suggested that *SLC27A2* may play a new role in regulating polyunsaturated fatty acid synthesis. *CRH* plays an important role as the major hypothalamic releasing factor for pituitary adrenocorticotropin (ACTH) secretion [@B62], which regulates cortisol level. Cortisol has profound metabolic effects, such as inhibiting glucose uptake and stimulating fat breakdown. SNPs of *CRH* in a Charolais-cross steer population were highly associated with end-of-test rib-eye area [@B63]. Our previously study demonstrated that *CRH* was significantly associated with marbling and subcutaneous fat depth (SFD) in a Wagyu×Limousin F~2~ population [@B64]. In the present study, we discovered a new role for *CRH* in lipid metabolism, i.e., it is significantly associated with both OMEGA-3 and the OMEGA 6:3 RATIO. In brief, we provided novel evidence of *SLC27A2*, *TFB2M*, and *CRH* genes in polyunsaturated fatty acid metabolism.

CLA positively affects human health by inhibiting carcinogenesis, reducing fat deposition, and reducing serum lipids [@B65]. Ruminant fats in meat are the primary dietary CLA sources for humans because plants do not synthesize CLA [@B66]. Three genes, *EFEMP1*, *PLTP*, and *DSEL*, were involved in the CLA network. PLTP is a lipid transfer protein that belongs to the lipopolysaccharide family. Previous reports revealed that plasma PLTP activity is elevated in type 2 diabetes mellitus, and obesity, with a decrease in PLTP being observed after weight loss [@B67]-[@B68]. Higher PLTP activity could contribute to elevated cardiovascular risk in the presence of obesity and insulin resistance [@B69]. Recently, a genome-wide association study showed a SNP locus of *PLTP* is significantly associated with HDL-cholesterol level in human, which is a risk factor of coronary heart disease [@B70]-[@B71]. In the present study, our association result also implied that *PLTP* may affect lipid level by regulating CLA. This is a good clue for improving the level of CLA in beef production by using genomic markers if we consider *PLTP* as a good candidate for decreasing the risk of coronary heart disease. DSEL acts as a chondroitin-glucuronate C5 epimerase, converting D-glucuronic acid to L-iduronic acid, and catalyzing the formation of dermatan sulfate from chondroitin sulfate [@B72]. Our previous study found *DSEL* has an overdominant effect on R2 (calculated as (16:1/16:0) × 100%) [@B11]. Now a different role has been discovered for the relationship between *DSEL* and CLA. Interestingly, the same genetic network is also responsible for both CLA and palmitoleic acid (C16:1n7). Overall, we discovered three different effects, an overdominant effect for *PLTP* and dominant effects for both *EFEMP1* and *DSEL*, which are involved in the same CLA network, suggesting the regulation of CLA may be more complex.

Beef fat is not only an excellent source of CLA, but it also contains large amounts of trans-vaccenic acid (trans-18:1n7t, TVA), which can be converted to CLA in the human body [@B73]. DELTA9 desaturase, the rate-limiting enzyme of MUFA, catalyzes the introduction of a double bond between carbons 9 and 10 of saturated fatty acids, such as palmitic (16:0) and stearic (18:0) acids, to yield palmitoleic (16:1n7) and oleic (18:1n9) acids, respectively, and also converts TVA to CLA [@B74]-[@B75]. We found that *GNG3* is associated with DELTA9 desaturase. GNG3 is one of the gamma subunits in the G protein subunit gene family, which is involved as modulators or transducers of various transmembrane signaling systems. Mice with a deficiency of GNG3 are lean and show resistance to opioids and diet-induced obesity [@B76]. But until now, the role of GNG3 was unclear. Our current results indicate that the *GNG3* gene plays an important role in the conversion process from saturated fatty acid to unsaturated fatty acid.

In summary, our present study revealed different gene networks were associated with important traits, i.e., BMS, REA, BFT, HCW, myristic acid (C14:0), palmitic acid (C16:0), oleic acid (C18:1n9), oleic acid (C18:1n9), OMEGA-3, OMEGA-6, OMEGA 6:3 RATIO, DELTA9, and CLA, in our Wagyu x Angus F~1~ population. Our present work also provides a novel view on origin of heterosis as a result of gene (allele) action changes during crossbreeding of different breeds. Furthermore, the SNPs evaluated in the present study are strong candidates for marker-assisted selection in the genomic improvement of carcass, meat quality, and healthful products of beef cattle.
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###### 

Linkage disequilibrium analysis for markers in 49 genes**.**Pairwise linkage disequilibrium relationships for these SNPs are based on r^2^ measurements. A-R represent BTA 1, 2, 3, 4, 7, 8, 10, 11, 14, 15, 16, 18, 19, 21, 23, 26, 28 and 29, respectively.
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###### 

Single marker-trait associations confirmed by linear regression analysis. A: *TNF* on BMS; B: *RCAN1* on REA; C: *ASB3* on BFT; D: *SLC27A1* on C15:0; E: *LIPE* on C18:2N6T; F: *SLC27A2* on PUFA; G: *CRH* on OMEGA-3; H: *SLC27A2* on OMEGA-6; I: *GNG3* on DELTA9; J: *SLC27A2* on Fat. The chart titles indicate the marker and the significant P-value of the linear regression analysis.
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###### 

Genetic networks with two genes established by linear regression analysis for economically important traits in beef cattle. The numbers in arrows represent substitution effects of one type of genotype or allele for another. Each combined genotype(s) between different genes has two means of performance: predicted (top) and actual (bottom). The chart titles indicate the marker and the Pearson correlation coefficients with its significant P-value between predicted and actual.
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###### 

Genetic networks with three genes established by linear regression analysis for economically important traits in beef cattle. The numbers in arrows represent substitution effects of one type of genotype or allele for another. Each combined genotype(s) among different genes has two means of performance: predicted (top or left side) and actual (bottom or right side). "-" means no animals were identified with the combined genotype (s) in the population. The chart titles indicate the marker and the Pearson correlation coefficients with its significant P-value between predicted and actual.
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![**Phenotypic classifications and their associated gene networks.**A total of 52 associations were orchestrated for gene networks with 19 genes. Four carcass traits, five saturated fatty acids, seven monounsaturated fatty acids, four polyunsaturated fatty acids, two trans-fatty acids and five traits related to enzyme activities or others are shown as Dark gray, Blue, Dark blue, Orange, Aqua and Green colors, respectively.](ijbsv08p0838g20){#F6}

###### 

Association of significant SNP markers with 29 economically important traits in beef and marker QTMs\*.

  Trait      Marker                  N1    Q   N2    G    LSM±SE               P           Trait       Marker                  N1    Q   N2    G    LSM±SE               P
  ---------- ----------------------- ----- --- ----- ---- -------------------- -------- -- ----------- ----------------------- ----- --- ----- ---- -------------------- --------
  BMS        TNF\#3 A/T              645   A   91    AA   6.8787±0.2982^a^     0.0016      C18:1n9     PSMG1\#1 A/C            319   O   59    AA   42.0533±0.4051^ab^   0.0408
                                               275   AT   7.3723±0.2269^a^                                                               179   AC   41.6613±0.2997^a^    
                                               279   TT   7.8107±0.2254^b^                                                               81    CC   42.5384±0.3639^b^    
  BMS        IGF2\#1 C/T             627   O   179   CC   7.1579±0.2619^a^     0.0161      C18:1n9     SLC27A1\#1 G/T          318   D   112   GG   41.3939±0.3434^a^    0.0155
                                               319   CT   7.7362±0.2351^b^                                                               151   GT   42.3725±0.3033^b^    
                                               129   TT   7.5411±0.2744^ab^                                                              55    TT   42.0665±0.4189^ab^   
  BMS        *ASB3\#2 C/T*           640       279   CC   7.1787±0.2339^a^     0.0026      C18:1n9     ABCA1\#7 A/G            312   D   21    AA   40.3968±0.5986^a^    0.0114
                                               359   CT   7.7674±0.2252^b^                                                               113   AG   42.2364±0.3162^b^    
                                               2     TT   7.7976±1.4338^ab^                                                              178   GG   42.0831±0.2829^b^    
                                                                                           C18:1n9     SLC27A2\#1 C/T          319   D   27    CC   43.1295±0.5434^a^    0.0370
  REA        RCAN1\#5 C/T            638   D   35    CC   12.1809±0.2148^a^    0.0103                                                    153   CT   41.9958±0.3059^ab^   
                                               480   CT   12.7929±0.1056^b^                                                              139   TT   41.7072±0.3223^b^    
                                               123   TT   12.7325±0.1335^b^                C18:1n9     EFEMP1\#2 A/C           319   D   114   AA   42.5363±0.3410^a^    0.0178
  REA        CAPN12\#1 I/D           631   O   67    II   12.4514±0.1690^a^    0.0099                                                    189   AC   41.6884±0.3029^b^    
                                               318   IT   12.8552±0.1136^b^                                                              16    CC   41.6262±0.7182^ab^   
                                               246   DD   12.6783±0.1192^ab^               C18:1n9     TFB2M\#2 C/T            310   O   93    CC   41.4395±0.3801^a^    0.0365
  REA        LIPE\#1 C/T             638   D   26    CC   12.1830±0.2351^a^    0.0177                                                    164   CT   42.3131±0.3278^b^    
                                               390   CT   12.7352±0.1085^b^                                                              53    TT   41.8789±0.4467^ab^   
                                               222   TT   12.8310±0.1180^b^                C18:1n9     DSEL\#1 C/T             320   D   112   CC   42.5322±0.3452^a^    0.0343
  REA        CRHR1\#1 A/G            633   D   177   AA   12.7084±0.1286^ab^   0.0391                                                    148   CT   41.7321±0.3142^b^    
                                               375   AG   12.8158±0.1145^a^                                                              60    TT   41.6584±0.4147^ab^   
                                               81    GG   12.4796±0.1630^b^                                                                                              
  REA        [MTFR1\#1 C/G]{.ul}     646       146   CC   12.5158±0.1446^a^    0.0474      C18:1n7     APOB\#2 C/T             323   O   40    CC   3.7696±0.2295^ab^    0.0019
                                               344   CG   12.8117±0.1172^a^                                                              225   CT   4.0884±0.1738^a^     
                                               156   GG   12.8551±0.1429^a^                                                              58    TT   3.5692±0.2110^b^     
                                                                                           C18:1n7     UTS2R\#2 I/D            325   O   142   II   3.7433±0.1841^a^     0.0031
  BFT        ASB3\#1 G/T             640   O   243   GG   0.7173±0.0198^a^     0.0392                                                    156   ID   4.1578±0.1828^b^     
                                               314   GT   0.7582±0.0189^b^                                                               27    DD   3.8438±0.2665^ab^    
                                               83    TT   0.7334±0.0260^ab^                C18:1n7     TFAM\#3 C/T             325   O   107   CC   3.7562±0.1917^a^     0.0134
  BFT        [ALDH4A1\#1 G/T]{.ul}   632       80    GG   0.7750±0.0263^a^     0.0328                                                    173   CT   4.1117±0.1819^b^     
                                               301   GT   0.7500±0.0192^a^                                                               45    TT   3.7999±0.2295^ab^    
                                               251   TT   0.7162±0.0199^a^                 C18:1n7     CAPN1\#1 C/G            323   D   128   CC   3.8201±0.1940^a^     0.0106
                                                                                                                                         161   CG   3.9166±0.1847^a^     
  QG         RCAN1\#5 C/T            511   D   30    CC   13.0899±0.1661^a^    0.0000                                                    34    GG   4.4702±0.2481^b^     
                                               385   CT   13.8295±0.0728^b^                C18:1n7     CAPN1\#5 A/G            325   D   50    AA   4.3967±0.2243^a^     0.0021
                                               96    TT   13.7488±0.1073^b^                                                              169   AG   3.9420±0.1840^b^     
  QG         ALDH4A1\#1 G/T          508   D   58    GG   13.4378±0.1277^a^    0.0115                                                    106   GG   3.7302±0.1974^b^     
                                               238   GT   13.8031±0.0801^b^                C18:1n7     [CRH\#3 C/G]{.ul}       323       34    CC   3.6775±0.2460^a^     0.0177
                                               212   TT   13.8215±0.0837^b^                                                              188   CG   4.1050±0.1834^a^     
  QG         LRPAP1\#1 C/T           514   D   81    CC   13.4919±0.1144^a^    0.0113                                                    101   GG   3.7931±0.1969^a^     
                                               222   CT   13.7745±0.0822^b^                C18:1n7     [SKIV2L\#1 C/T]{.ul}    324       84    CC   3.8167±0.2103^a^     0.0381
                                               211   TT   13.8506±0.0838^b^                                                              157   CT   3.8763±0.1857^a^     
  QG         CAST\#2 C/T             518   D   39    CC   13.4334±0.1500^a^    0.0394                                                    83    TT   4.2204±0.2047^a^     
                                               235   CT   13.8189±0.0828^b^                                                                                              
                                               244   TT   13.7859±0.0826^ab^               C18:2n6t    LIPE\#1 C/T             318   A   15    CC   0.3460±0.0221^ab^    0.0131
  QG         FTO\#3 C/T              509   O   186   CC   13.6188±0.0869^a^    0.0021                                                    191   CT   0.3714±0.0097^a^     
                                               259   CT   13.9097±0.0812^b^                                                              112   TT   0.3946±0.0106^b^     
                                               64    TT   13.6592±0.1277^ab^               C18:2n6t    [SCP2\#1 A/G]{.ul}      318       14    AA   0.3443±0.0226^a^     0.0466
  QG         TNF\#3 A/T              517   D   66    AA   13.4994±0.1190^a^    0.0290                                                    139   AG   0.3899±0.0111^a^     
                                               217   AT   13.7684±0.0797^ab^                                                             165   GG   0.3739±0.0106^a^     
                                               234   TT   13.8300±0.0779^b^                                                                                              
  QG         DHCR7\#2 A/G            523   D   216   AA   13.8381±0.0808^a^    0.0001      MUFA        PSMG1\#1 A/C            318   O   60    AA   51.3753±0.4676^ab^   0.0157
                                               289   AG   13.7733±0.0743^a^                                                              177   AC   50.8816±0.3788^a^    
                                               18    GG   12.9737±0.1990^b^                                                              81    CC   51.9133±0.4335^b^    
                                                                                           MUFA        SLC27A1\#1 G/T          317   D   109   GG   50.5009±0.3992^a^    0.0027
  YG         HMGCL\#1 A/G            641   D   16    AA   4.0484±0.2350^ab^    0.0196                                                    153   GT   51.7196±0.3588^b^    
                                               301   AG   3.8261±0.0876^a^                                                               55    TT   51.5203±0.4676^ab^   
                                               324   GG   3.6885±0.0852^b^                 MUFA        ABCA1\#7 A/G            312   D   22    AA   49.6734±0.6498^a^    0.0077
  YG         APOB\#2 C/T             634   D   84    CC   3.5764±0.1027^a^     0.0105                                                    112   AG   51.6650±0.4002^b^    
                                               449   CT   3.7860±0.0859^b^                                                               178   GG   51.3120±0.3709^b^    
                                               101   TT   3.8064±0.1161^ab^                MUFA        SLC27A2\#1 C/T          318   D   27    CC   53.0719±0.5922^a^    0.0006
  YG         ASB3\#1 G/T             634   D   240   GG   3.6712±0.0903^a^     0.0325                                                    151   CT   51.2234±0.3751^b^    
                                               313   GT   3.8266±0.0888^b^                                                               140   TT   50.8665±0.3894^b^    
                                               81    TT   3.7972±0.1118^ab^                MUFA        DSEL\#1 C/T             319   D   109   CC   51.9722±0.4281^a^    0.0073
  YG         CAPN5\#3 A/G            622   D   328   AA   3.8131±0.0878^a^     0.0088                                                    150   CT   50.9171±0.3970^b^    
                                               248   AG   3.7282±0.0893^ab^                                                              60    TT   51.0153±0.4871^ab^   
                                               46    GG   3.5111±0.1161^b^                                                                                               
  YG         FTO\#8 C/T              633   O   301   CC   3.8695±0.0911^a^     0.0045      PUFA        ABCA1\#7 A/G            313   O   21    AA   2.2766±0.1008^ab^    0.0437
                                               289   CT   3.6587±0.0882^b^                                                               113   AG   2.2167±0.0640^a^     
                                               43    TT   3.7323±0.1290^ab^                                                              179   GG   2.3371±0.0597^b^     
  YG         TNF\#3 A/T              638   O   91    AA   3.7494±0.1172^ab^    0.0010      PUFA        SLC27A2\#1 C/T          320   A   27    CC   2.1306±0.0912^a^     0.0074
                                               270   AT   3.8957±0.0961^a^                                                               151   CT   2.2743±0.0598^ab^    
                                               277   TT   3.6626±0.0939^b^                                                               142   TT   2.3712±0.0617^b^     
  YG         TFAM\#3 C/T             620   D   223   CC   3.7472±0.0912^a^     0.0211      PUFA        CRHR1\#1 A/G            320   O   92    AA   2.2585±0.0673^ab^    0.0138
                                               314   CT   3.7378±0.0886^a^                                                               185   AG   2.3356±0.0606^a^     
                                               84    TT   4.0105±0.1219^b^                                                               43    GG   2.1458±0.0817^b^     
  YG         [LIPE\#1 C/T]{.ul}      636       26    CC   4.1643±0.2051^a^     0.0373      PUFA        SKIV2L\#1 C/T           320   O   82    CC   2.1987±0.0658^a^     0.0326
                                               387   CT   3.7795±0.0856^a^                                                               155   CT   2.3415±0.0582^b^     
                                               223   TT   3.6978±0.0897^a^                                                               83    TT   2.2875±0.0661^ab^    
                                                                                                                                                                         
  HCW        SLC27A4\#2 C/T          647   D   252   CC   878.59±13.6600^a^    0.0305      SFA         SLC27A1\#1 G/T          319   D   113   GG   39.5921±0.2330^a^    0.0031
                                               315   CT   862.85±13.4855^b^                                                              152   GT   38.7575±0.2001^b^    
                                               80    TT   864.63±15.2369^ab^                                                             54    TT   38.6805±0.2996^b^    
  HCW        TFB2M\#1 C/T            641   D   238   CC   880.55±13.5547^a^    0.0219      SFA         ABCA1\#2 A/G            311   D   32    AA   39.8422±0.3693^a^    0.0409
                                               301   CT   863.69±13.2943^b^                                                              159   AG   39.0961±0.2092^ab^   
                                               101   TT   864.28±14.6212^ab^                                                             120   GG   38.8307±0.2247^b^    
  HCW        TFB2M\#2 C/T            621   A   174   CC   858.94±13.6556^a^    0.0238      SFA         ABCA1\#7 A/G            313   D   22    AA   40.0681±0.4352^a^    0.0225
                                               303   CT   870.08±13.1404^ab^                                                             114   AG   39.1215±0.2295^ab^   
                                               144   TT   881.75±13.8614^b^                                                              177   GG   38.8523±0.2070^b^    
  HCW        CAPN12\#1 I/D           632   A   67    II   851.09±14.4969^a^    0.0319      SFA         DSEL\#1 C/T             321   D   113   CC   38.5723±0.2402^a^    0.0106
                                               318   ID   867.39±11.8914^ab^                                                             147   CT   39.2817±0.2116^b^    
                                               247   DD   877.37±12.1458^b^                                                              61    TT   39.3180±0.2928^ab^   
  HCW        TNF\#3 A/T              645   D   91    AA   877.20±14.7955^ab^   0.0087      SFA         [TFAM\#2 C/T]{.ul}      321       48    CC   39.3908±0.3172^a^    0.0471
                                               275   AT   877.88±13.1753^a^                                                              167   CT   38.7811±0.2107^a^    
                                               279   TT   858.85±13.1555^b^                                                              106   TT   39.2679±0.2393^a^    
  HCW        [APOE\#4 C/T]{.ul}      641       35    CC   884.74±18.1782^a^    0.0438                                                                                    
                                               394   CT   872.78±13.2659^a^                CLA         CAST\#2 C/T             318   D   24    CC   0.9573±0.0205^a^     0.0446
                                               212   TT   859.50±13.7205^a^                                                              132   CT   0.9047±0.0104^b^     
                                                                                                                                         162   TT   0.9060±0.0100^ab^    
  C14:0      CAST\#2 C/T             315   D   23    CC   3.3057±0.0975^a^     0.0328      CLA         TFB1M\#1 G/T            323   O   29    GG   0.9139±0.0193^ab^    0.0218
                                               132   CT   3.0755±0.0656^b^                                                               132   GT   0.8907±0.0101^a^     
                                               160   TT   3.1194±0.0650^ab^                                                              162   TT   0.9229±0.0097^b^     
  C14:0      ABCA1\#7 A/G            313   D   21    AA   3.3618±0.1024^a^     0.0048      CLA         EFEMP1\#2 A/C           324   D   114   AA   0.8851±0.0113^a^     0.0042
                                               114   AG   3.1401±0.0666^ab^                                                              194   AC   0.9221±0.0096^b^     
                                               178   GG   3.0657±0.0631^b^                                                               16    CC   0.9246±0.0260^ab^    
  C14:0      CAPN14\#2 A/G           317   D   116   AA   3.2001±0.0648^a^     0.0166      CLA         PLTP\#2 C/T             315   O   82    CC   0.8858±0.0135^a^     0.0042
                                               171   AG   3.0594±0.0620^b^                                                               164   CT   0.9282±0.0108^b^     
                                               30    GG   3.0849±0.0894^ab^                                                              69    TT   0.9009±0.0145^ab^    
  C14:0      EFEMP1\#2 A/C           320   A   112   AA   3.0373±0.0672^a^     0.0283      CLA         DSEL\#1 C/T             325   D   114   CC   0.8836±0.0109^a^     0.0044
                                               192   AC   3.1516±0.0622^b^                                                               150   CT   0.9226±0.0096^b^     
                                               16    CC   3.2244±0.1173^ab^                                                              61    TT   0.9216±0.0139^b^     
  C14:0      CRHR1\#1 A/G            321   D   92    AA   3.1463±0.0693^a^     0.0177      CLA         [ABCA1\#7 A/G]{.ul}     317       22    AA   0.9436±0.0218^a^     0.0222
                                               185   AG   3.1372±0.0623^a^                                                               115   AG   0.9226±0.0111^a^     
                                               44    GG   2.9411±0.0864^b^                                                               180   GG   0.8959±0.0098^a^     
  C14:0      TNF\#3 A/T              320   D   45    AA   3.2604±0.0859^a^     0.0100      CLA         [ASB3\#1 G/T]{.ul}      324       128   GG   0.8916±0.0105^a^     0.0459
                                               131   AT   3.0575±0.0670^b^                                                               154   GT   0.9196±0.0097^a^     
                                               144   TT   3.1329±0.0671^ab^                                                              42    TT   0.9213±0.0163^a^     
  C14:0      CAPN1\#3 A/G            321   O   29    AA   3.1482±0.0943^ab^    0.0070                                                                                    
                                               159   AG   3.0336±0.0665^a^                 TRANS       ABCA1\#7 A/G            313   O   21    AA   6.0375±0.3813^ab^    0.0251
                                               133   GG   3.2002±0.0677^b^                                                               114   AG   5.3747±0.2552^a^     
  C14:0      [APOB\#2 C/T]{.ul}      319       40    CC   3.0372±0.0834^a^     0.0362                                                    178   GG   5.8040±0.2434^b^     
                                               221   CT   3.0915±0.0614^a^                 TRANS       SLC27A2\#1 C/T          319   D   27    CC   4.9060±0.3362^a^     0.0040
                                               58    TT   3.2444±0.0791^a^                                                               151   CT   5.6774±0.2302^b^     
                                                                                                                                         141   TT   5.9110±0.2376^b^     
  C14:1n5    ALDH4A1\#1 G/T          313   D   47    GG   1.0792±0.1100^a^     0.0387      TRANS       FADS2\#1 A/G            320   D   115   AA   5.4532±0.2449^a^     0.0008
                                               149   GT   1.2297±0.1012^b^                                                               167   AG   5.6051±0.2289^a^     
                                               117   TT   1.2131±0.1023^ab^                                                              38    GG   6.4917±0.3106^b^     
  C14:1n5    PCSK1\#2 C/T            322   O   75    CC   1.1089±0.1014^a^     0.0450      TRANS       [SLC27A1\#1 G/T]{.ul}   318       112   GG   5.8670±0.2590^a^     0.0492
                                               194   CT   1.2299±0.0963^b^                                                               151   GT   5.4910±0.2416^a^     
                                               53    TT   1.1715±0.1050^ab^                                                              55    TT   5.9031±0.2904^a^     
  C14:1n5    ABCA1\#7 A/G            316   D   22    AA   1.2685±0.1214^ab^    0.0066      TRANS       [APOA1\#2 A/G]{.ul}     311       3     AA   7.2593±0.8453^a^     0.0308
                                               115   AG   1.2682±0.1001^a^                                                               94    AG   5.4303±0.2611^a^     
                                               179   GG   1.1374±0.0980^b^                                                               214   GG   5.7376±0.2382^a^     
  C14:1n5    SLC27A2\#1 C/T          323   D   27    CC   1.3524±0.1145^a^     0.0153                                                                                    
                                               153   CT   1.1987±0.0960^ab^                OMEGA-3     CRH\#3 C/G              315   O   30    CC   0.1316±0.0090^a^     0.0200
                                               143   TT   1.1385±0.0971^b^                                                               185   CG   0.1115±0.0061^b^     
  C14:1n5    ACSL5\#1 C/T            323   O   123   CC   1.1735±0.0990^ab^    0.0413                                                    100   GG   0.1207±0.0067^ab^    
                                               149   CT   1.2390±0.0982^a^                 OMEGA-3     IGF2\#1 C/T             310   O   82    CC   0.1268±0.0072^a^     0.0347
                                               51    TT   1.1005±0.1065^b^                                                               173   CT   0.1121±0.0062^b^     
  C14:1n5    [SCD1\#2 A/G]{.ul}      314       14    AA   1.0891±0.1357^a^     0.0463                                                    55    TT   0.1191±0.0077^ab^    
                                               134   AG   1.1478±0.1001^a^                 OMEGA-3     [TFB2M\#1 C/T]{.ul}     317       157   CC   0.1115±0.0066^a^     0.0179
                                               166   GG   1.2442±0.0994^a^                                                               108   CT   0.1227±0.0061^a^     
                                                                                                                                         52    TT   0.1072±0.0079^a^     
  C15:0      SLC27A1\#1 G/T          321   D   112   GG   0.7055±0.0198^a^     0.0195                                                                                    
                                               154   GT   0.6708±0.0188^b^                 OMEGA-6     ABCA1\#7 A/G            315   O   21    AA   2.1607±0.1009^ab^    0.0466
                                               55    TT   0.6718±0.0216^ab^                                                              114   AG   2.1045±0.0648^a^     
                                                                                                                                         180   GG   2.2222±0.0607^b^     
  C15:1n5    TFB2M\#1 C/T            321   D   110   CC   0.0939±0.0026^a^     0.0109      OMEGA-6     SLC27A2\#1 C/T          322   A   27    CC   2.0325±0.0916^a^     0.0121
                                               158   CT   0.1014±0.0023^b^                                                               152   CT   2.1577±0.0610^ab^    
                                               53    TT   0.1032±0.0035^b^                                                               143   TT   2.2533±0.0627^b^     
  C15:1n5    TNF\#3 A/T              320   D   45    AA   0.0964±0.0036^ab^    0.0156      OMEGA-6     CRHR1\#1 A/G            322   O   93    AA   2.1480±0.0679^ab^    0.0253
                                               130   AT   0.0953±0.0023^a^                                                               185   AG   2.2158±0.0616^a^     
                                               145   TT   0.1029±0.0023^b^                                                               44    GG   2.0416±0.0816^b^     
                                                                                           OMEGA-6     SKIV2L\#1 C/T           322   D   83    CC   2.0891±0.0667^a^     0.0436
  C16:0      ABCA1\#7 A/G            317   D   22    AA   25.0129±0.4259^a^    0.0025                                                    156   CT   2.2233±0.0596^b^     
                                               115   AG   24.1660±0.2849^ab^                                                             83    TT   2.1710±0.0672^ab^    
                                               180   GG   23.7658±0.2708^b^                OMEGA-6     [RCAN1\#6 C/T]{.ul}     321       14    CC   1.9818±0.1195^a^     0.0257
  C16:0      PLTP\#2 C/T             315   O   82    CC   23.8683±0.3162^ab^   0.0055                                                    249   CT   2.2078±0.0567^a^     
                                               164   CT   24.2921±0.2838^a^                                                              58    TT   2.0942±0.0729^a^     
                                               69    TT   23.5817±0.3302^b^                                                                                              
  C16:0      TNF\#3 A/T              324   D   45    AA   24.7247±0.3603^a^    0.0043      OMEGA-6:3   CRH\#3 C/G              315   D   33    CC   16.6578±1.5585^a^    0.0054
                                               132   AT   23.7729±0.2772^b^                                                              182   CG   21.0695±1.0786^b^    
                                               147   TT   24.0488±0.2768^ab^                                                             100   GG   20.2472±1.1780^b^    
  C16:0      [LRPAP1\#1 C/T]{.ul}    321       45    CC   23.9383±0.3487^a^    0.0450      OMEGA-6:3   TFB2M\#1 C/T            317   O   109   CC   21.0956±1.1514^ab^   0.0015
                                               152   CT   24.2678±0.2752^a^                                                              156   CT   19.0225±1.0867^a^    
                                               124   TT   23.7613±0.2793^a^                                                              52    TT   22.8876±1.3706^b^    
                                                                                           OMEGA-6:3   PNPLA2\#1 C/G           315   D   83    CC   20.0462±1.1625^ab^   0.0272
  C16:1n7    ABCA1\#7 A/G            317   A   22    AA   3.0133±0.0670^a^     0.0162                                                    163   CG   19.6211±1.0328^a^    
                                               115   AG   2.9232±0.0338^ab^                                                              67    GG   22.3840±1.2291^b^    
                                               180   GG   2.8456±0.0299^b^                 OMEGA-6:3   *CRH\#2 A/G*            316       13    AA   20.6608±2.1540^ab^   0.0336
  C16:1n7    ASB3\#1 G/T             324   D   128   GG   2.8265±0.0322^a^     0.0266                                                    100   AG   21.8716±1.1010^a^    
                                               154   GT   2.9231±0.0293^b^                                                               203   GG   19.6002±0.9859^b^    
                                               42    TT   2.9165±0.0498^ab^                OMEGA-6:3   [IGF2\#1 C/T]{.ul}      309       85    CC   19.1924±1.1687^a^    0.0411
  C16:1n7    EFEMP1\#2 A/C           324   D   114   AA   2.8193±0.0340^a^     0.0121                                                    169   CT   21.2254±1.0191^a^    
                                               194   AC   2.9221±0.0287^b^                                                               55    TT   19.0672±1.2844^a^    
                                               16    CC   2.9301±0.0804^ab^                                                                                              
  C16:1n7    PLTP\#2 C/T             315   O   82    CC   2.8119±0.0406^a^     0.0012      DELTA9      SLC27A2\#1 C/T          320   D   26    CC   83.2946±0.7098^a^    0.0189
                                               164   CT   2.9526±0.0322^b^                                                               152   CT   81.9178±0.4681^ab^   
                                               69    TT   2.8539±0.0440^ab^                                                              142   TT   81.4771±0.4825^b^    
  C16:1n7    DSEL\#1 C/T             325   D   114   CC   2.8138±0.0336^a^     0.0112      DELTA9      TFB2M\#1 C/T            321   D   110   CC   82.5440±0.5159^a^    0.0255
                                               150   CT   2.9224±0.0294^b^                                                               159   CT   81.5615±0.4769^b^    
                                               61    TT   2.9243±0.0428^ab^                                                              52    TT   81.4223±0.6053^ab^   
  C16:1n7    [TFB1M\#1 G/T]{.ul}     323       29    GG   2.9296±0.0596^a^     0.0337      DELTA9      GNG3\#2 G/T             313   A   24    GG   80.7177±0.7156^a^    0.0115
                                               132   GT   2.8319±0.0307^a^                                                               140   GT   81.4788±0.4522^ab^   
                                               162   TT   2.9197±0.0298^a^                                                               149   TT   82.3947±0.4532^b^    
                                                                                           DELTA9      [SLC27A1\#1 G/T]{.ul}   319       113   GG   81.2776±0.4968^a^    0.0482
  C17:0      ABCA1\#7 A/G            312   D   22    AA   1.7990±0.0850^a^     0.0326                                                    152   GT   82.0319±0.4607^a^    
                                               114   AG   1.9288±0.0637^ab^                                                              54    TT   82.5316±0.5732^a^    
                                               176   GG   1.9730±0.0616^b^                 DELTA9      [APOE\#5 A/G]{.ul}      313       29    AA   82.4964±0.6825^a^    0.0316
  C17:0      CAPN12\#1 I/D           316   D   35    II   2.1017±0.0766^a^     0.0049                                                    181   AG   81.4557±0.4722^a^    
                                               166   ID   1.9263±0.0599^b^                                                               103   GG   82.3526±0.5136^a^    
                                               115   DD   1.9058±0.0626^b^                                                                                               
  C17:0      FADS2\#1 A/G            320   D   114   AA   1.9479±0.0631^ab^    0.0253      ELONGASE    ABCA1\#7 A/G            317   D   22    AA   63.7281±0.6657^a^    0.0020
                                               169   AG   1.9128±0.0602^a^                                                               115   AG   65.3718±0.4377^b^    
                                               37    GG   2.0617±0.0749^b^                                                               180   GG   65.8435±0.4146^b^    
  C17:0      *SCD\#2 A/G*            310       14    AA   2.1306±0.0976^a^     0.0389      ELONGASE    EFEMP1\#2 A/C           324   D   114   AA   66.0452±0.4422^a^    0.0210
                                               132   AG   1.9519±0.0623^ab^                                                              194   AC   65.2039±0.4098^b^    
                                               164   GG   1.9152±0.0614^b^                                                               16    CC   65.2053±0.7816^ab^   
                                                                                           ELONGASE    PLTP\#2 C/T             315   O   82    CC   65.7275±0.4940^ab^   0.0044
  C17:1n7    FABP4\#1 A/G            317   O   60    AA   1.3475±0.0470^a^     0.0415                                                    164   CT   65.0435±0.4422^a^    
                                               174   AG   1.2727±0.0416^b^                                                               69    TT   66.1899±0.5160^b^    
                                               83    GG   1.3054±0.0445^ab^                ELONGASE    TNF\#3 A/T              324   D   45    AA   64.5268±0.5653^a^    0.0192
  C17:1n7    CAPN12\#1 I/D           320   D   35    II   1.3838±0.0527^a^     0.0209                                                    132   AT   65.8124±0.4316^b^    
                                               168   ID   1.2905±0.0416^b^                                                               147   TT   65.4346±0.4309^ab^   
                                               117   DD   1.2681±0.0433^b^                 ELONGASE    [TFB1M\#1 G/T]{.ul}     323       29    GG   65.2667±0.6134^a^    0.0440
  C17:1n7    FADS2\#1 A/G            324   D   115   AA   1.2992±0.0433^ab^    0.0206                                                    132   GT   65.9508±0.4165^a^    
                                               171   AG   1.2735±0.0414^a^                                                               162   TT   65.1806±0.4165^a^    
                                               38    GG   1.3759±0.0511^b^                 ELONGASE    [DSEL\#1 C/T]{.ul}      325       114   CC   66.0345±0.4416^a^    0.0420
  C17:1n7    *SCD\#2 A/G*            314       14    AA   1.4237±0.0666^a^     0.0168                                                    150   CT   65.2389±0.4138^a^    
                                               135   AG   1.3095±0.0432^ab^                                                              61    TT   65.1955±0.4981^a^    
                                               165   GG   1.2677±0.0427^b^                                                                                               
                                                                                           FAT         PCSK1\#2 C/T            319   D   75    CC   81.0719±2.4719^ab^   0.0325
  C18:1n7t   ABCA1\#2 A/G            310   D   30    AA   4.6378±0.3285^a^     0.0250                                                    191   CT   80.3735±2.4141^a^    
                                               162   AG   5.1515±0.2346^ab^                                                              53    TT   82.8640±2.5188^b^    
                                               118   GG   5.4210±0.2413^b^                 FAT         SLC27A2\#1 C/T          320   D   26    CC   78.1833±2.6485^a^    0.0333
  C18:1n7t   ABCA1\#7 A/G            312   O   20    AA   5.4669±0.3725^ab^    0.0398                                                    153   CT   80.8826±2.4034^ab^   
                                               114   AG   4.9779±0.2441^a^                                                               141   TT   81.6011±2.4143^b^    
                                               178   GG   5.3914±0.2327^b^                 FAT         CAPN1\#2 C/T            312   D   141   CC   80.2166±2.4515^a^    0.0117
  C18:1n7t   SLC27A2\#1 C/T          318   D   27    CC   4.5148±0.3209^a^     0.0054                                                    145   CT   81.4189±2.4505^ab^   
                                               151   CT   5.2744±0.2178^b^                                                               26    TT   83.9212±2.6843^b^    
                                               140   TT   5.4578±0.2256^b^                 FAT         PNPLA2\#3 C/T           317   D   64    CC   82.8295±2.5200^a^    0.0128
  C18:1n7t   FADS2\#1 A/G            319   D   114   AA   5.0141±0.2305^a^     0.0003                                                    160   CT   80.6430±2.4508^b^    
                                               167   AG   5.1991±0.2142^a^                                                               93    TT   79.9845±2.4870^b^    
                                               38    GG   6.0840±0.2936^b^                 FAT         *TNF\#5 C/T*            319       197   CC   81.0481±2.4115^a^    0.0265
  C18:1n7t   [APOA1\#2 A/G]{.ul}     310       3     AA   6.8097±0.8099^a^     0.0246                                                    120   CT   80.9194±2.4464^a^    
                                               94    AG   5.0101±0.2476^a^                                                               2     TT   69.2402±4.9516^b^    
                                               213   GG   5.3177±0.2255^a^                 FAT         [CAPN1\#1 C/G]{.ul}     319       127   CC   81.9978±2.4602^a^    0.0459
                                                                                                                                         158   CG   80.4552±2.4445^a^    
                                                                                                                                         34    GG   79.6255±2.6184^a^    

\*The different lowercase letters between different genotypes within the same marker indicate that the difference reached the significance level of P\<0.05, while the same letters between genotypes show no significant difference (P\>0.05). A, D and O represent additive, dominant and overdominant effects in the QTMs analysis respectively. The markers that do not show any significance among different genotypes after Bonferroni correction are underlined. The significant markers that have ≤ 15 animals in each genotype group are italicized.

Q = QTMs; G=Genotypes
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